Journal article

Routine HbA1c among hematology and oncology inpatients: Diabetes-status and hospital-outcomes

Wei-Ling Chiu, Leonid Churilov, Chee-Hau Lim, Alanna Tan, Rithin Nedumannil, Lik-Hui Lau, Jeremy Lew, Mariam Hachem, Alvin Kong, Raymond Robbins, Harvey Sutcliffe, Que Lam, Andrew Lee, Frida Djukiadmodjo, Natalie Nanayakkara, Jeffrey D Zajac, Elif I Ekinci

Diabetes Research and Clinical Practice | ELSEVIER IRELAND LTD | Published : 2019


AIMS: Using routine HbA1c measurement to determine the prevalence of diabetes mellitus (known and previously unrecognized) and their hospital outcomes among hematology and oncology inpatients. METHODS: This was a prospective, observational study. Routine automated HbA1c testing was performed in all hematology and oncology inpatients aged ≥54 years at a tertiary hospital, July 2013-January 2015. The outcome measures were: (i) prevalence of known and previously unrecognized diabetes, and (ii) hospital outcomes: length-of-stay (LOS), intensive-care-unit (ICU) admission, 30-day/18-month readmission, and 18-month mortality. RESULTS: Over the 18-month study period, 1076 inpatients aged ≥54 years w..

View full abstract